MGC Pharma Reports Strongest Ever Sales as Key Drug Approvals Remain in Limbo
MGC Pharmaceutical has reported its strongest ever quarterly sales figures, but a lack of significant progress on its drug trials and regulatory approvals saw a muted response from investors. The young Australian pharmaceuticals company, which is developing a number of cannabis-based drugs to treat Alzheimer’s, Dementia, [...]